Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2007
06/13/2007CN1980891A Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS)
06/13/2007CN1980659A Indoles having anti-diabetic activity
06/13/2007CN1978428A Method for preparing (3R, %S)-Fluvastatin
06/13/2007CN1321118C 5-aza-indole preparation method
06/13/2007CN1321111C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
06/13/2007CN1321110C 4-piperazinylindole derivatives with 5-HT6 receptor affinity
06/12/2007US7230118 By reacting indole-4-carboxaldehyde with nitromethane, reducing the nitro group to form an amine, propylating the amine group, oxidizing the 2 C atom in the indole ring, and optionally forming a salt, especially the hydrochloride
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230026 Selected fused pyrrolocarbazoles
06/12/2007US7230022 Substituted fused bicyclic amines as modulators of chemokine receptor activity
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7229986 Melanin-concentrating hormone antagonist
06/12/2007US7229799 System and method for nucleic acid sequencing by polymerase synthesis
06/12/2007CA2354023C Phenylglycine derivatives
06/12/2007CA2239569C Improved metal-ligand complex catalyzed processes
06/12/2007CA2238410C Novel indole-2,3-dione-3-oxime derivatives
06/12/2007CA2173418C Benzonitriles and benzofluorides
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064630A1 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compounds and methods for making them
06/07/2007WO2007064569A2 Chromane substituted 2 -alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
06/07/2007WO2007063986A1 Diaminoarylene compound having carbazolyl group and use thereof
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007WO2007063010A1 Novel vinylogous acids derivatives
06/07/2007WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007WO2007062994A1 Methods for synthesis of 3-amino-1-arylpropyl indoles
06/07/2007WO2007062963A1 Oxime ester photoinitiators
06/07/2007WO2007062865A1 Process for the preparation of perindopril and salts thereof
06/07/2007WO2007043354A9 Spirofluorene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic device
06/07/2007WO2007030940A3 Methods of modulating neurotrophin-mediated activity
06/07/2007WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
06/07/2007WO2006097809B1 Novel tyrosine derivatives
06/07/2007US20070129422 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
06/07/2007US20070129397 Ester derivatives
06/07/2007US20070129347 Cyclohexylacetic acid compounds
06/07/2007US20070129252 2-Halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives
06/07/2007US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2631232A1 Novel vinylogous acids derivatives
06/07/2007CA2631048A1 Methods for synthesis of 3-amino-1-arylpropyl indoles
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/06/2007EP1792897A2 Intercalators having affinity for DNA and methods of use
06/06/2007EP1792896A1 Process for the preparation of perindopril and salts thereof
06/06/2007EP1792893A1 Aromatic amine derivative and organic electroluminescent device using same
06/06/2007EP1791843A2 Monocyclic anilide spirolactam cgrp receptor antagonists
06/06/2007EP1791825A1 Benzoyl-substituted serine amides
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
06/06/2007EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
06/06/2007DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids
06/06/2007CN1976932A Fused quinoline derivative and use thereof
06/06/2007CN1976900A Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
06/06/2007CN1976883A Polycyclic aromatic compound, material for forming luminescent coating film and organic electroluminescent device using same
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1974553A Prepn process of Ropinirole and its derivative
06/06/2007CN1974552A Indole producing process
06/06/2007CN1974545A Long chain fatty acyl amide compound and its application
06/06/2007CN1320378C Filters for electronic displays
06/06/2007CN1319973C Piperidine derivatives
06/06/2007CN1319971C Camptothecine derivatives and their use
06/06/2007CN1319944C Preparation process of N-methyl-4-(dimethyl phenoxy) phthalimide
06/06/2007CN1319943C Crystals of non-natural-type stereoisomer salt of monatin and use thereof
06/06/2007CN1319929C Aryl phenyl substituted cyclic ketoenols
06/06/2007CN1319532C Use of N-(indolecarbonyl-)piperazine derivatives
06/05/2007US7227027 Bis(carbazole) carboaromatics; triplet emissive dyes with high energy and stability; improved luminance and efficiency of triplet blue organic light emitting devices
06/05/2007US7226942 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
06/05/2007US7226915 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
06/05/2007US7226546 Organic host material for an organic luminescence layer of a carbazole derivative with a glass-transition temperature of 110 degrees C., and a phosphorescent dopant; heat-resistance
06/05/2007CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
06/05/2007CA2157586C Indoletetralins having dopaminergic activity
05/2007
05/31/2007WO2007060974A1 Pharmaceutical for use in the treatment of ureterolithiasis
05/31/2007WO2007059663A1 N-isoindol-dione-substituted phenylurea compounds having herbicidal activity
05/31/2007WO2007059662A1 N-isoindol-dione-substituted phenylamide compounds having herbicidal activity
05/31/2007WO2007017289A3 Acyltryptophanols for fertility control
05/31/2007WO2007014851A3 Indol-3-yl-carbonyl-piperidin and piperazin derivatives
05/31/2007WO2007003947A3 Process for the synthesis of the ace inhibitor trandolapril
05/31/2007WO2006013581A3 Resolution of racemic organic acids with (1s, 4s)-4[3,4-dichlorophenyl]-1,2,3,4- tetrahydro-n-methyl-1-naphthaloneamine
05/31/2007US20070123715 catalysis the reaction of an aryl boronic compound, and a conjugate acceptor 2-cyclohexen-1-one to form a phenylcyclohexanone derivatives; transferring a carbon group from the boronic compound to the conjugate acceptor via the rhodium hydroquinone catalyst; drug medicinal discovery chemistry
05/31/2007US20070123714 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compounds and methods for making them
05/31/2007US20070123713 Polycyclic dihydroxy compound and methods for preparation
05/31/2007US20070123712 Dissolving 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidine in solvent; forming an adduct of the 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidine; heating the mixture to decompose the adduct to form a 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidine
05/31/2007US20070123711 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole)
05/31/2007US20070123581 Coupling, hydrogenation, catalysis; reacting benzyl indole-2-carboxylate with acid and alanine compound; amidation, salt formation
05/31/2007US20070123579 Process for preparing a dipeptidyl peptidase iv inhibitor and intermediates employed therein
05/31/2007US20070123543 Novel compounds
05/31/2007US20070123529 Substituted biphenyl compounds
05/31/2007US20070123528 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity
05/31/2007US20070123493 Benzamide derivative
05/31/2007CA2630234A1 Thrombopoietin activity modulating compounds and methods
05/31/2007CA2630046A1 Fluorescent membrane intercalating probes and methods for their use
05/31/2007CA2628527A1 Modulators of the h3 receptor useful for the treatment of disorders related thereto
05/31/2007CA2628476A1 Pharmaceutical for use in the treatment of ureterolithiasis
05/30/2007EP1790635A2 Processes for preparing amorphous fluvastatin sodium
05/30/2007EP1790634A2 Fluvastatin sodium crystal form and processes for preparing it
05/30/2007EP1789387A1 Perfected process for the preparation of stable nitroxide radicals
05/30/2007EP1789386A1 Substituted indole compounds, their preparation and use in medicaments
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors